AC Immune (ACIU) Restructuring Costs (2021 - 2025)
AC Immune's (ACIU) quarterly Restructuring Costs came in at $15014.0 in Q4 2025, up 102.57% on a QoQ basis from -$583801.1 in Q3 2025.
AC Immune (ACIU) Restructuring Costs (2021 - 2025) Analysis & Trends
AC Immune (ACIU) has 2 years of Restructuring Costs data on file, last reported at $15014.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | AC Immune | 222.66 Mn | 222.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15,014.04 |
| Sep 30, 2025 | -583,801.14 |
| Jun 30, 2021 | 449,625.32 |